MedTrace Logo

Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia

NCT07138131 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-08-22

No results posted yet for this study

Summary

This study aimed to evaluate the effect of omega-3 supplementation on heart rate (HR) control and heart rate variability (HRV) in children with inappropriate sinus tachycardia (IST).

Conditions

  • Omega 3
  • Treatment
  • Inappropriate Sinus Tachycardia

Interventions

DRUG

Omega 3

Patients received omega-3 supplementation for 3 months.

OTHER

Standard follow-up

Patients received standard follow-up without treatment.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-09-01
Completion
2024-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07138131 on ClinicalTrials.gov